WHO ICTRP trial
Third line H. pylori eradication therapy with sitafloxacin, amoxicillin and…
JPRN-UMIN000022235 · Japan Primary Registries Network (JPRN) · Not Recruiting
Key facts
| Trial ID | JPRN-UMIN000022235 |
|---|---|
| Public title | Third line H. pylori eradication therapy with sitafloxacin, amoxicillin and vonaprazan |
| Scientific title | Third line H. pylori eradication therapy with sitafloxacin, amoxicillin and vonaprazan - Third line H. pylori eradication therapy with sitafloxacin, amoxicillin and vonaprazan |
| Primary sponsor | Keio University School of Medicine |
| Registry | Japan Primary Registries Network (JPRN) |
| Recruitment status | Not Recruiting |
| Study type | Interventional |
| Phase | Phase III |
| Countries | Japan |
| Conditions | H. pylori-positve patients after the 2nd line eradication failure |
| Interventions | vonaprazan 40mg, b.i.d., amoxicillin 2.0g, q.i.d., sitafloxacin 200 mg, b.i.d. |
| Registration date | Sep 5, 2016 |
| Target size | 100 |
| Registry page | center6.umin.ac.jp |
At a glance
- Yes Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: